Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

Healthcare Drug Manufacturers - Specialty & Generic
"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

MERUS LABS INTERNATIONAL INC
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Post by kdog1caon Jul 09, 2015 12:58pm
143 Views
Post# 23907756

Updated Level 2

Updated Level 2

Expand/Contract LEVEL 2 QUOTE


Market Maker Shares Bid Price Ask Price Shares Market Maker
  1,800 2.960 2.970 1,700  
  6,700 2.950 2.980 3,500  
  1,500 2.940 2.990 17,300  
  3,600 2.930 3.000 50,300  
  100 2.920 3.010 5,300  
  11,000 2.900 3.020 5,800  
  2,000 2.890 3.030 3,700  
  13,700 2.880 3.050 5,500  
  300 2.870 3.060 200  
  3,600 2.860 3.070 800

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities